Skip to content

Clinical trials

Completed Schizophrenia trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Status: Completed Country / region: United Kingdom Clear all

82 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20031
20045
20053
20062
20072
20082
20094
20104
20116
20122
20134
20149
20153
20165
20177
20184
20195
20201
20213
20224
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed82

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
King's College London10
GlaxoSmithKline9
Otsuka Pharmaceutical Development & Commercialization, Inc.8
Janssen-Cilag International NV5
Autifony Therapeutics Limited4
Hoffmann-La Roche4
Boehringer Ingelheim3
University of Manchester3
Alkermes, Inc.2
AstraZeneca2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia82
Psychotic Disorders25
Bipolar Disorder8
Mental Disorders4
Anxiety Disorders3
Cognitive Dysfunction3
Depressive Disorder3
Adjustment Disorders2
Cognition Disorders2
Major Depressive Disorder2

Trials

Showing 1 to 25 of 82. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.